Heart Disease
Medline Studies
Scientific Studies
Oral EDTA
Competitive Products
Toxic Metals
Main Technical Section For  Chelation Therapy On Line

Vibrant Life Home Web
Family Of Three Chelation Formulas
MSM
Other VL Products
The Wednesday Letter
Frequently Asked Questions
Testimonials
Heart Disease & Bypass Surgery Home Page

Shopping Cart

Separate Search Page
or search below


Navigation Help

Karl Loren Background

Ingredients
Technical
Write To Karl Loren Table Of Contents

Study HMG-CoA reductase inhibitor  & Cholesterol

 
Relevance
Score
 
Search Results  
Documents 1 to 20 of 46    
74% 1. Regulation of hepatic cholesterol metabolism in humans: stimulatory effects of ... Reihnér Reihnér_E Angelin Angelin_B Rudling Rudling_M Ewerth Ewerth_S Björkhem Björkhem_I Einarsson Einarsson_K Medline/1990/12/9121/7555 91217555 Perl Medline ...
73% 2. Effect of long-term cholesterol-lowering treatment with HMG-CoA reductase inhibitor ... Hosokawa Hosokawa_R Nohara Nohara_R Linxue Linxue_L Tamaki Tamaki_S Hashimoto Hashimoto_T Tanaka Tanaka_M Miki Miki_S Sasayama Sasayama_S Medline/2000/03/2019/4986 ...
69% 3. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary ... Chikamori Chikamori_T Sugimoto Sugimoto_K Hamada Hamada_T Kitaoka Kitaoka_H Furuno Furuno_T Seo Seo_H Doi Doi_Y Medline/2000/02/2017/8269 20178269 Perl ...
68% 4. Feedback and hormonal regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A ... Ness Ness_GC Chambers Chambers_CM Medline/2000/05/2024/5638 20245638 Perl Medline Formatter 1.0 2000 05 01 UNITED STATES 2000 05 09 2000 05 17 8-19 ENG ...
68% 5. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and ... Honda Honda_A Salen Salen_G Honda Honda_M Batta Batta_AK Tint Tint_GS Xu Xu_G Chen Chen_TS Tanaka Tanaka_N Shefer Shefer_S Medline/2000/02/2015/8210 ...
66% 6. Regulation of cholesterol synthesis by oleic and palmitic acid in keratinocytes. Siefken Siefken_W Höppner Höppner_H Harris Harris_IR Medline/2000/04/2023/3342 20233342 Perl Medline Formatter 1.0 2000 04 01 DENMARK 2000 06 2000 06 15 138 ...
66% 7. Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by ... Salazar Salazar_LA Hirata Hirata_MH Quintão Quintão_EC Hirata Hirata_RD Medline/2000/01/2025/9915 20259915 Perl Medline Formatter 1.0 2000 01 UNITED STATES ...
65% 8. Regulation of HMG-CoA synthase and HMG-CoA reductase by insulin and epidermal growth factor ... Harris Harris_IR Höppner Höppner_H Siefken Siefken_W Farrell Farrell_AM Wittern Wittern_KP Medline/2000/01/2008/7062 20087062 Perl Medline Formatter 1.0 ...
63% 9. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering? März März_W Wieland Wieland_H Medline/2000/03/2028/8060 20288060 Perl Medline Formatter 1.0 2000 03 01 GERMANY 2000 06 23 2000 08 22 117-25 ENG Herz F88 M 2 25 0340-9937 1 ...
62% 10. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into ... Istvan Istvan_ES Palnitkar Palnitkar_M Buchanan Buchanan_SK Deisenhofer Deisenhofer_J Medline/2000/00/2016/4450 20164450 Perl Medline Formatter 1.0 2000 00 ...
60% 11. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, ... Nguyen Nguyen_LB Cobb Cobb_M Shefer Shefer_S Salen Salen_G Ness Ness_GC Tint Tint_GS Medline/1991/12/9227/6978 92276978 Perl Medline Formatter 1.0 1991 12 01 ...
60% 12. Intrahepatic biliary cholesterol and phospholipid transport in humans: effect of obesity ... Ahmed Ahmed_HA Jazrawi Jazrawi_RP Goggin Goggin_PM Dormandy Dormandy_J Northfield Northfield_TC Medline/1995/12/9640/1562 96401562 Perl Medline Formatter ...
60% 13. HMG-CoA reductase inhibitors in the prevention of stroke. van van_Mil_AH Westendorp Westendorp_RG Bollen Bollen_EL Lagaay Lagaay_AM Blauw Blauw_GJ Medline/2000/01/2018/1024 20181024 Perl Medline Formatter 1.0 2000 01 NEW ZEALAND 2000 03 28 ...
56% 14. Regulation of intracellular cholesterol metabolism. Sato Sato_R Takano Takano_T Medline/1995/12/9642/2445 96422445 Perl Medline Formatter 1.0 1995 12 01 JAPAN 1996 12 05 2000 03 29 421-7 ENG Cell Struct Funct CSF M 6 20 0386-7196 ...
56% 15. Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of ... Kato Kato_T Tokoro Tokoro_T Namii Namii_Y Kobayashi Kobayashi_T Hayashi Hayashi_S Yokoyama Yokoyama_I Morimoto Morimoto_S Chan Chan_M Giannetti Giannetti_N Hunt ...
56% 16. Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic ... Mascaró Mascaró_C Ortiz Ortiz_JA Ramos Ramos_MM Haro Haro_D Hegardt Hegardt_FG Medline/2000/00/2013/2866 20132866 Perl Medline Formatter 1.0 2000 00 01 ...
55% 17. Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated ... Rustemeijer Rustemeijer_C Schouten Schouten_JA Voerman Voerman_HJ Hensgens Hensgens_HE Donker Donker_AJ Heine Heine_RJ Medline/2000/00/2021/7297 ...
54% 18. Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia ... Spieker Spieker_LE Noll Noll_G Hannak Hannak_M Lüscher Lüscher_TF Medline/2000/03/2017/3353 20173353 Perl Medline Formatter 1.0 2000 03 01 UNITED STATES 2000 04 ...
53% 19. HMG-CoA reductase inhibitors (statins): a promising approach to stroke prevention. Hess Hess_DC Demchuk Demchuk_AM Brass Brass_LM Yatsu Yatsu_FM Medline/2000/00/2015/2823 20152823 Perl Medline Formatter 1.0 2000 00 01 UNITED STATES 2000 03 29 2000 04 ...
52% 20. Prevention of cardiovascular disease. Haines Haines_A Patterson Patterson_D Rayner Rayner_M Hyland Hyland_K Medline/1992/12/9425/8143 94258143 Perl Medline Formatter 1.0 1992 12 01 ENGLAND 1994 07 2000 04 07 67-78 ENG Occas ...
 

Copyright © 1997-2000 NBCi and its content providers. All rights reserved.

Relevance
Score
 
Search Results  
Documents 21 to 40 of 46    
51% 21. Control of sterol metabolism in cultured rat granulosa cells. Rosenblum Rosenblum_MF Huttler Huttler_CR Strauss Strauss_JF_3d Medline/1981/11/8205/0399 82050399 Perl Medline Formatter 1.0 1981 11 01 UNITED STATES 1982 01 09 2000 04 ...
51% 22. New molecular targets for cholesterol-lowering therapy. Izzat Izzat_NN Deshazer Deshazer_ME Loose Loose_Mitchell_DS Medline/2000/05/2023/7733 20237733 Perl Medline Formatter 1.0 2000 05 01 UNITED STATES 2000 06 21 2000 08 19 315 ...
48% 23. Comparative study of the kinetics of 3-hydroxy-3-methylglutaryl coenzyme A reductase and ... Tabacik Tabacik_C Astruc Astruc_M Laporte Laporte_M Descomps Descomps_B Crastes Crastes_de_Paulet_A Serrou Serrou_B Medline/1981/12/8216/1211 82161211 Perl ...
47% 24. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy. Buemi Buemi_M Allegra Allegra_A Corica Corica_F Aloisi Aloisi_C Giacobbe Giacobbe_M Pettinato Pettinato_G Corsonello Corsonello_A Senatore Senatore_M Frisina Frisina_N ...
47% 25. Statins: effective antiatherosclerotic therapy. Blumenthal Blumenthal_RS Medline/2000/04/2020/6258 20206258 Perl Medline Formatter 1.0 2000 04 01 UNITED STATES 2000 06 01 2000 06 12 577-83 ENG Am Heart J 3BW 1 M 4 139 0002-8703 1 ...
46% 26. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. ... Hunninghake Hunninghake_DB Mellies Mellies_MJ Goldberg Goldberg_AC Kuo Kuo_PT Kostis Kostis_JB Schrott Schrott_HG Insull Insull_W_Jr Pan Pan_HY ...
46% 27. HDL steady state levels are not affected, but HDL apoA-I turnover is enhanced by Lifibrol ... Winkler Winkler_K Schaefer Schaefer_JR Klima Klima_B Nuber Nuber_C Friedrich Friedrich_I Köster Köster_W Gierens Gierens_H Scharnagl Scharnagl_H Soufi ...
45% 28. Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: ... Le Le_NA Innis Innis_Whitehouse_W Li Li_X Bakker Bakker_Arkema_R Black Black_D Brown Brown_WV Medline/2000/02/2015/2799 20152799 Perl Medline Formatter ...
45% 29. Positron emission tomography and the changing paradigm in coronary artery disease. Schelbert Schelbert_HR Medline/2000/01/2027/1074 20271074 Perl Medline Formatter 1.0 2000 01 GERMANY 2000 06 02 2000 06 15 IV55-60 IV55-60 ENG Z Kardiol XW7 M 89 Suppl 4 ...
45% 30. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic ... Dobs Dobs_AS Miller Miller_S Neri Neri_G Weiss Weiss_S Tate Tate_AC Shapiro Shapiro_DR Musliner Musliner_TA Medline/2000/01/2011/0994 20110994 Perl Medline ...
45% 31. Current perspectives on statins. Maron Maron_DJ Fazio Fazio_S Linton Linton_MF Medline/2000/00/2010/5254 20105254 Perl Medline Formatter 1.0 2000 00 01 UNITED STATES 2000 02 01 2000 02 09 207-13 ENG Circulation DAW 1 M 2 ...
44% 32. Oral contraceptive steroids and atherosclerosis: lipogenesis in human arterial smooth ... Subbaiah Subbaiah_PV Bagdade Bagdade_JD Medline/1980/01/8106/1877 81061877 Perl Medline Formatter 1.0 1980 01 UNITED STATES 1981 01 29 2000 04 19 437-57 ENG ...
42% 33. What is the role of lipid lowering therapy in heart-allograft failure? Reichart Reichart_B Meiser Meiser_BM Wenke Wenke_K Brandl Brandl_U Seidel Seidel_D Thiery Thiery_J Medline/1995/12/9616/4103 96164103 Perl Medline Formatter 1.0 1995 12 01 UNITED ...
42% 34. The evolving role of statins in the management of atherosclerosis. Vaughan Vaughan_CJ Gotto Gotto_AM_Jr Basson Basson_CT Medline/2000/01/2010/0207 20100207 Perl Medline Formatter 1.0 2000 01 UNITED STATES 2000 01 24 2000 02 07 1-10 ENG ...
42% 35. Direct effects of statins on cells primarily involved in atherosclerosis. Chen Chen_H Ikeda Ikeda_U Shimpo Shimpo_M Shimada Shimada_K Medline/2000/03/2023/1036 20231036 Perl Medline Formatter 1.0 2000 03 01 JAPAN 2000 06 21 2000 08 19 187 ...
42% 36. Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients [see ... Hölschermann Hölschermann_H Hilgendorff Hilgendorff_A Kemkes Kemkes_Matthes_B Schönburg Schönburg_M Bauer Bauer_EP Tillmanns Tillmanns_H Haberbosch ...
40% 37. Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at ... Fonarow Fonarow_GC Gawlinski Gawlinski_A Medline/2000/00/2015/8249 20158249 Perl Medline Formatter 1.0 2000 00 01 UNITED STATES 2000 03 13 2000 03 31 10A-17A ...
39% 38. Clinical utility of antilipidemic therapies in chronic renal allograft failure. Wanner Wanner_C Bartens Bartens_W Galle Galle_J Medline/1995/12/9616/4105 96164105 Perl Medline Formatter 1.0 1995 12 01 UNITED STATES 1996 03 27 2000 03 29 S60-2 ...
39% 39. The interaction of diltiazem with simvastatin. Mousa Mousa_O Brater Brater_DC Sunblad Sunblad_KJ Hall Hall_SD Medline/2000/03/2020/3674 20203674 Perl Medline Formatter 1.0 2000 03 01 UNITED STATES 2000 04 11 2000 04 26 267-74 ENG ...
39% 40. Simvastatin-induced lupus-like syndrome. Ahmad Ahmad_A Fletcher Fletcher_MT Roy Roy_TM Medline/2000/01/2009/3749 20093749 Perl Medline Formatter 1.0 2000 01 UNITED STATES 2000 02 22 2000 03 08 21-2 ENG Tenn Med CJX 1 93 ...
 

Copyright © 1997-2000 NBCi and its content providers. All rights reserved.


If you missed it, you can go to either a SHORT explanation of the whole story, or a detailed explanation on ONE PAGE.  On this page you are getting more detail on one part of the story, but on either of those pages you can get the broad picture.  Don't miss reading one of them.  You can actually spend many hours on this web site, depending on the depth of research and reading you want to do.  There are an amazing 4,000 pages here -- more information on these general subjects than almost all other web sites combined!  At some point along the way you will probably say, "Karl's crazy," and leave never to return to this site, or you will say "I want to try some of that oral chelation formula he writes about!"

 


Special Pages On The Various of 12 Web Sites Authored by Karl Loren
OC History Oral Chelation Testimonials
Family Of Three Oral Chelation Formulas Life Glow Basic Life Glow Basic Ingredient List
Life Glow Plus Life Glow Plus
Ingredient List
American Heart Association -- Lies
Super Life Glow Super Life Glow
 Ingredient List
FAQ
All Products Shopping Cart Order Section Research
Taheebo Life Tea Witch Doctors Versus Harvard MSM Sulfur
Calcium How Bones Grow Colloidal Minerals
Jean Ross Philosophy The Wednesday Letter
Arthritis & James Coburn's Use Of MSM Karl Loren Viewpoints News And Announcements
Dr. Flanagan's Microhydrin 500 Page Book On Heart Disease Colostrum & Transfer Factor
Germanium Ultrasound Technology Bulk MSM
Cancer & Biopsy Diabetes Heart Disease & Bypass Surgery
Karl Loren's Diet Guarantee Navigation Help Page
The Links Below Jump To Pages On Whatever Web You Are In
Table Of Contents Search This Web Navigation Help Page
Write To Karl Loren -- He Pledges To Answer EVERY Personal Message, Personally.  Click here or on his name in the box below.
The Links Below Are To Various Web Sites Published By Karl Loren
Karl Loren Web Vibrant Life Web Karl Loren's Book
Super Colostrum Bulk MSM Heart Disease
Emmessar Happiness Arthritis
Instead Of Chelation Therapy Super Colostrum (2)
Karl Loren's Catalog Store Central Page For All 12 Webs!
 

I promise to answer your message -- click here to send me a personal message

Dear Karl,                                        

 

 

 

 

SUBSCRIBE:  The Wednesday Letter is a free electronic monthly newsletter written and published by Karl Loren.  You can view more than 50 back issues of this publication by clicking here.  The Wednesday Letter subscription list is maintained on a secure server, no name is ever given or sold to anyone, and it is never used except for this Newsletter.  It is automatically published on the Tuesday night just before the first Wednesday of every month.  You can subscribe to this free monthly electronic letter by entering your eMail address and name below.  You will then automatically receive a request for confirmation, sent to whatever address you have entered.  If you do NOT receive this confirmation request, then you will not be subscribed.  There may have been an error with your address and you should resubmit.  The letter is never sent twice to the same address -- so you do not have to worry about a duplicate subscription.  When you receive this confirmation request you must reply to it, or your subscription will not become active.  No one can subscribe your name, and address, without you being notified, and if you get an unwanted notice of subscription you only need to DO NOTHING and the subscription will NOT be active.

E-Mail Address:
First Name:
Last Name:

REMOVAL:  You can remove yourself from the subscription list in several different ways.  Click here to read about this entire newsletter system.  Every edition of The Wednesday Letter is delivered to your address with YOUR name and address in view on the letter, with a link that allows you to remove THAT name from the subscription list.  If you try to send this removal message from an address different from the one you used to send in your original confirmation, then you will get a warning notice first, sent to the subscription address, asking you to confirm that you want to be removed from the list -- by replying to THAT request for confirmation, you will then be automatically removed.  Thus, no one else can unsubscribe you, from some other computer, without your knowledge.  But, if you send in the unsubscribe notice from the same machine used to receive the Letter, then the removal from the subscription list is automatic.

E-Mail Address:

Personal Message:  When you send a personal message to Karl Loren, you will receive a personal reply as per his instructions.  Karl pledges that every personal message will get a personal answer. When you provide your mail address, we will send you free information including our free catalog and a cassette tape lecture by Karl Loren about heart disease, no charge, by mail, even if outside the US.  You can select particular information you would like to receive, along with the free cassette tape and catalog.

You can reach Vibrant Life in many ways, including by mail to Vibrant Life, 2808 N. Naomi St., Burbank, CA 91504.  Within the US and Canada, use the toll free number:  (800) 523-4521, the local number:  (818) 558-1799, the FAX:  (818) 558-7299, eMail to kimberly@oralchelation.com or any one of the hundreds of message forms throughout the 50 web sites.  Vibrant Life normally ships the same day we get an order.  There are message forms on each of the 100,000+ pages on this and other sites where you can communicate with Vibrant Life.  Check out our companion site, at:  http://www.oralchelation.net where Karl's 2000 page book is published.  Karl Loren is the author and webmaster for this BOOK, as well as for another web site about ORAL CHELATION.  His personal philosophical articles are at PHILOSOPHY

Copyright © May 20, 2008 6:25 AM by Karl Loren on behalf of Vibrant Life, ALL RIGHTS RESERVED.  Permission is granted for non-commercial downloading, copying, distribution or redistribution on two conditions:  One, that some form of copyright notice is included in every copy distributed or copied, showing the copyright belonging to Vibrant Life, Burbank, CA, at www.oralchelation.com . The second condition is that the material is not to be used for any purpose contrary to the purposes and objectives of this site.  This permission does not extend to materials on this site which are copyrighted by others.